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S U M M A R Y
Background: During July 2010, newspapers reported a respiratory disease outbreak in southwestern
Bangladesh resulting in the admission of children to a secondary care hospital. We investigated this
outbreak to determine the etiology and explore possible risk factors.
Methods: The hospital’s physician diagnosed children aged <2 years with cough, tachypnea or dyspnea,
and expiratory wheeze as having acute bronchiolitis. We reviewed the hospital records and listed case
patients admitted between 26 June and 26 July 2010. We surveyed the case patients and collected nasal
and throat swabs to test for respiratory viruses.
Results: We identiﬁed 101 admitted acute bronchiolitis case patients. Fifty-nine (58%) of these were
admitted between 16 and 20 July. Among the 29 case patients surveyed, the median age was 4 months
and 65% were males. We identiﬁed respiratory syncytial virus (RSV) in 91% (21/23) of the samples, 43% of
which had a dual viral infection. Most case patients (90%) were treated with broad-spectrum antibiotics.
There were no reported deaths.
Conclusions: The sudden increase in admitted acute bronchiolitis case patients, their median age, and
identiﬁcation of RSV in the majority of samples suggest an outbreak of RSV bronchiolitis. Research to
identify strategies to prevent respiratory infections including RSV in low-income settings should be
prioritized. Factors that perpetuate antibiotic use in managing this viral syndrome should also be
explored.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. 
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Respiratory syncytial virus (RSV) is recognized globally as the
leading cause of acute bronchiolitis both in epidemics and sporadic
cases.1–3 Although disease burden data from low-income countries
are limited, extrapolation using data from high-income countries
suggests an estimated annual global RSV burden of approximately
64 million cases with 160 000 annual deaths.4–6 It is estimated that
2–3% of all children aged <1 year require hospitalization during
seasonal RSV epidemics.3,6
Acute bronchiolitis is a potentially life-threatening lower
respiratory tract infection in infants that results from inﬂamma-
tory obstruction of the small airways.1,3 Although bronchiolitis is§ Presented as an abstract at the International Conference on Emerging Infectious
Diseases, Atlanta, Georgia, USA, March 11–14, 2012.
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http://dx.doi.org/10.1016/j.ijid.2012.07.016common and most infants recover, the lack of a standard case
deﬁnition,7 little knowledge about what makes infants particularly
vulnerable to RSV, and no recommended speciﬁc therapy, all make
bronchiolitis prevention and management difﬁcult for clinicians,
researchers, and public health professionals.3 Adding to the clinical
perplexity, the data on disease burden, epidemiology, seasonality,
risk factors, and clinical proﬁles of bronchiolitis are limited in the
majority of resource-limited settings, including Bangladesh.
The Institute of Epidemiology, Disease Control and Research
(IEDCR), the Government of Bangladesh’s institute responsible for
outbreak investigations and disease surveillance, contracts a
media agency to scan reports from 10 national newspapers and
six popular local television channels on a daily basis and forward
reports of potential outbreaks to IEDCR authorities. Several
newspapers ﬁrst reported an outbreak of a pneumonia-like illness
that affected ‘‘hundreds of children’’ <2 years of age who were
seeking admission to a government secondary care hospital in
Meherpur District in southwestern Bangladesh during July 17–18,
2010. Within the disease surveillance team, these media reports Ltd. Open access under the Elsevier OA license.
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pathogen of public health importance, and so a collaborative team
from IEDCR and the International Centre for Diarrhoeal Disease
Research, Bangladesh (ICDDR,B) investigated this outbreak during
July 2010. This paper summarizes the results of the outbreak
investigation, which aimed to determine the etiology of illness,
explore possible exposures, and describe the clinical proﬁles of
case patients to recommend possible control and prevention
measures.
2. Methods
2.1. Outbreak veriﬁcation, case detection, and descriptive
investigation
To collect preliminary information and verify the occurrence of
the outbreak that was reported in the newspapers, the outbreak
investigation team contacted the Civil Surgeon of Meherpur
District and the Upazila Health and Family Planning Ofﬁcers of
Gangni and Mujibnagar subdistricts (upazilas). From 24 to 26 July
2010, the team visited Meherpur General Hospital and collected
information on patient demographics (age, gender, and address),
dates of admission and discharge, and the diagnoses from the
hospital’s registry. In order to simplify case management of
childhood illnesses including acute respiratory infections (ARI) and
diarrheal diseases at the primary health care settings, the
Government of Bangladesh introduced the Integrated Manage-
ment of Childhood Illnesses (IMCI) strategy nationwide in 2002.
According to this IMCI guideline, any child aged <5 years
presenting with cough and fast breathing and/or difﬁcult breathing
for less than 30 days and with any general danger sign (unable to
drink or breast feed, vomits everything, convulsions, lethargy,
grunting, fever of 37.5 8C or above or feels hot, low body
temperature of less than 35.5 8C or feels cold, movement only
when stimulated, no movement at all, unconsciousness), or chest
indrawing or stridor in a calm child, was categorized as a case of
ARI.8 We assumed that the hospital physicians used this IMCI case
deﬁnition during admissions to classify patients presenting with
respiratory symptoms under the broad category of ARI. Following
admission, the single pediatrician at the hospital re-assessed all
admitted ARI patients and diagnosed children aged <2 years who
initially developed coryza and/or low-grade fever followed by
cough, fast breathing (tachypnea) or shortness of breath (dyspnea),
and expiratory wheeze8,9 as acute bronchiolitis. From the
hospital’s registry, we listed all children aged <5 years who were
admitted with ARI between 26 June and 26 July 2010. We also
listed the patients diagnosed as cases of acute bronchiolitis
between 26 June and 26 July 2010 and sought hospital records to
note their clinical prognosis. We chose the 30-day time period to
permit comparison of the monthly admission rates for acute
bronchiolitis with previous months. We requested the Civil
Surgeon to review the hospital records and then report to IEDCR
the total number of patients discharged with a diagnosis of acute
bronchiolitis who were classiﬁed using the same criteria by the
pediatrician in the Meherpur General Hospital from January to
December 2010.
To describe the outbreak in terms of persons, the team surveyed
the case patients who were still in the hospital during the period of
the investigation. We selected the mother as the primary survey
respondent to provide information regarding her child’s health. If
the mother was unavailable, we interviewed other family
members. We explored clinical histories of these case patients,
including exposure to possible risk factors, using a pretested,
structured questionnaire that was jointly developed by IEDCR and
ICDDR,B for investigating respiratory disease outbreaks. Physicians
on the outbreak investigation team physically examined thehospitalized case patients looking for symptoms and signs of
illness severity including central (bluish tongue) and peripheral
cyanosis (bluish limbs).10–12 The team recorded both the clinical
features they observed and those reported in the patient
information sheet by the attending physician during admission.
We reviewed the patient treatment records to gather information
regarding clinical management.
To determine if the acute bronchiolitis case patients surveyed in
the hospital were similar to or different from those already
discharged prior to the investigation and to identify possible
clusters, we segregated the 101 cases in the line-list (identiﬁed
from the hospital’s registry) based on the villages where they lived.
The team deﬁned a cluster of bronchiolitis if at least three admitted
bronchiolitis cases came from the same village and lived within
15 min walking distance from each other according to the local
community health worker. The team visited village communities
with suspected clusters to survey and physically examine selected
acute bronchiolitis cases who had been discharged from the
hospital after June 26 until the beginning of the investigation. The
team collected information on demographic and clinical proﬁles
and exposures of these bronchiolitis cases from their mothers (or
family members if the mother was not available) using the same
questionnaire that was used for the hospital survey. Team
members also visited the three government-run primary care
hospitals of the district to seek additional cases of acute
bronchiolitis in admitted children aged <2 years.
2.2. Laboratory investigations
The investigation team collected nasal and throat swabs from
all bronchiolitis case patients surveyed in the hospital and from
those discharged case patients who were still symptomatic during
the cluster investigation. Following collection, both samples
obtained from the same patient were immediately placed in a
single vial with viral transport medium containing DMEM
(Dullbecco’s modiﬁed Eagle’s medium), 2.5% BSA (bovine serum
albumin) fraction V, 1% glutamine, 2% HEPES (4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid), 1% penicillin–streptomycin, and
Fungizone (250 mg/ml). The specimens were stored at 4–8 8C until
transported within 72 h to IEDCR. The specimens were aliquoted in
a biosafety level 2 safety cabinet and were stored in freezers at or
below 70 8C until testing. At the Virology Laboratory of IEDCR, we
performed RNA extraction and detected subtypes of inﬂuenza A
and inﬂuenza B using a real-time reverse transcriptase polymerase
chain reaction (rRT-PCR).13 Both RNA and DNA extraction were
performed in a separate aliquot sent to the Virology Laboratory of
ICDDR,B for molecular identiﬁcation of other common respiratory
viruses and bacteria. A real-time PCR respiratory pathogen panel
assay developed by the Centers for Disease Control and Prevention
(CDC), Atlanta, Georgia, USA, was used to detect respiratory
pathogens including RSV, human parainﬂuenza virus 1, 2, and 3
(HPIV1, HPIV2, and HPIV3), human metapneumovirus (HMPV),
adenovirus, Chlamydia pneumoniae, Mycoplasma pneumoniae,
Streptococcus pneumoniae, Legionella pneumophila, and Legionella
longbeachae.
2.3. Ethical considerations
We sought verbal informed consent from a parent of all
participants. We suggested simple preventive measures including
hand washing, and social distancing measures including cancella-
tion of sports events to protect the wider community of the cluster
villages. We also advised that parents avoid taking their ill child to
public gatherings including mosques, weddings, and schools. This
investigation was conducted in response to an outbreak and was
approved by the Government of the People’s Republic of
Figure 1. Total monthly acute bronchiolitis admissions in the Meherpur General
Hospital, Bangladesh during 2010.
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activity was not reviewed by an independent human subjects
committee.
3. Results
3.1. Spatial distribution, demographic, and clinical proﬁles of case
patients
Acute bronchiolitis cases were admitted to Meherpur General
Hospital throughout the year. However, monthly acute bronchiol-
itis admissions increased between June and October, with the
highest number of admissions occurring during July 2010
(Figure 1). We identiﬁed 101 children who were hospitalizedFigure 2. Daily acute bronchiolitis admissions in the Mehand diagnosed with acute bronchiolitis between 26 June and 26
July 2010. Compared to the previous month, acute bronchiolitis
admissions increased by more than 60% during the month of July
2010 (Figure 1), with more than half of these cases (59/101)
admitted between 16 and 20 July 2010 (Figure 2). Of the 258
children hospitalized with acute respiratory infections (ARIs)
during this month, 101 (39%) had a discharge diagnosis of acute
bronchiolitis. All except nine cases lived in different communities
within the three subdistricts of Meherpur (Figure 3). Fifty-six
percent (57/101) of the cases lived in the urban subdistrict, while
the rest lived in the two other rural subdistricts (Mujibnagar and
Gangni). We surveyed 20 case patients admitted to Meherpur
General Hospital and nine from the two villages where we had
identiﬁed clusters. The mean age of the 29 case patients was 5.4
months (median 4 months); 65% (19/29) were males and the
average monthly household income was US$ 53 (range US$ 22–
124).
The main clinical symptoms included cough, fast breathing,
shortness of breath, and feeding difﬁculty. About a quarter (7/29)
reported a family history of atopy (deﬁned as having asthma,
eczema, or allergic rhinitis in the parents, or siblings or grand-
parents); 17% (5/29) of case patients had been affected at least once
before with a similar illness that required hospitalization and 35%
(10/29) were born prematurely. Thirty-one percent of respondents
also reported that either another sibling or an extended family
member had developed similar symptoms (cough/fast breathing/
respiratory difﬁculty with a preceding mild fever/runny nose)
within 1 week following the onset of illness in the child affected
with bronchiolitis. All case patients were treated with supplemen-
tal oxygen, oral or inhalational bronchodilators, and nasal
decongestants. Among the chest radiographs from nine case
patients, the hospital’s pediatrician found patchy opacities or
radiological evidence of bacterial pneumonia in only one case
patient. Ninety percent (26/29) of the case patients received at
least one broad-spectrum injectable antibiotic. There were no
reported deaths from bronchiolitis or its complications among the
29 case patients (Table 1). As the hospital’s registry did not record
patient outcome, we tried to assess the illness outcome of the
remaining 72 cases by reviewing patient information sheets
including copies of discharge and/or death certiﬁcates. We found
that 75% (54/72) of the cases were discharged alive and 8% (6/72)erpur General Hospital, Bangladesh during July 2010.
Figure 3. Map showing the approximate location of the general (district) hospital and the three RSV outbreak affected upazilas of Meherpur District.
F. Haque et al. / International Journal of Infectious Diseases 16 (2012) e866–e871 e869were discharged against medical advice, a decision that families in
low-income countries often make because of their inability to
afford continued hospitalization, poor response to treatment, or
dissatisfaction with the hospital environment.14 We could not
retrieve the information sheets of 12 patients and the hospital
records were insufﬁcient to evaluate their outcomes.
3.2. Laboratory ﬁndings
Among the 29 acute bronchiolitis patients surveyed, we
collected samples from 23 cases (including samples from all the
20 hospitalized cases and from three symptomatic discharged
cases). Out of the 23 samples tested for different respiratory
pathogens, 21 had detectable RNA for RSV, one had inﬂuenza A
(H1N1), and one had inﬂuenza B. More than one virus was
identiﬁed in 43% (9/21) of the RSV-positive cases. These co-
infections included RSV with inﬂuenza A/H1N1 (n = 6), with
inﬂuenza B (n = 1), and with adenovirus (n = 2) (Table 2). We did
not detect any nucleic acids for bacterial pathogens in the
specimens.
4. Discussion
The sharp rise in the number of infant hospitalizations with a
diagnosis of acute bronchiolitis heralded the occurrence of an
outbreak in southwestern Bangladesh. We identiﬁed RSV in 91% ofthe samples tested from children hospitalized with acute
bronchiolitis, which is comparable with ﬁndings from previous
seasonal epidemics in other countries.15–19 The median age of the
affected children was 4 months, consistent with RSV bronchiolitis
data from previous hospital-based studies.19,20 Seventeen percent
of the case patients in our investigation had been hospitalized at
least once before with similar symptoms within 1 year. Although
RSV can re-infect, often with the same serotype, these prior
admissions may also have been from other respiratory viruses
including adenovirus, human metapneumovirus, and parain-
ﬂuenza virus circulating earlier in the year.
Nine out of the 21 respiratory specimens with detectable RNA
from RSV also had detectable RNA from at least one other viral
respiratory pathogen. This result supports previous studies, which
have found a strong association between dual viral infections and
severe bronchiolitis requiring hospitalization.21 In many commu-
nities the RSV epidemic period overlaps with human metapneu-
movirus (HMPV) seasonal epidemics, and co-infection with RSV
and HMPV has been commonly reported in previous investiga-
tions.22–24 However, our investigation found co-infections of RSV
with H1N1, adenovirus, and inﬂuenza B virus. A previous study
from Bangladesh that detected HMPV circulation during January
through the end of June also detected co-infection of HMPV with
inﬂuenza A virus but not RSV.22 This investigation carried out at
the end of July was apparently conducted during a time when
HMPV was not circulating.
Table 1
Possible exposures, clinical presentation, management, and clinical outcome of case
patients admitted with acute bronchiolitis in Meherpur General Hospital, July 24–
26, 2010
Total number
(%) (N = 29)
Risk factorsa
Passive smoking 8 (28)
Positive family history of atopy
(asthma/allergic rhinitis/eczema)
7 (24)
Prematurity (reported by mothers
as delivery before 9 completed
months)
10 (35)
Twin/multiple birth 0 (0)
Exposure to multiple children (as
in a health care setting/older
siblings within the household)
6 (21)
Recommended feeding practices
(exclusive breast feeding for
<6 months/softened family
foods in addition to breast
milk for >6 months)
9 (31)
Past history of similar illness 5 (17)
Past history of similar illness
requiring hospitalization
5 (17)
Close contact with any sick
person 15 days prior to illness
9 (31)
Close contact with a sick family
member 15 days prior to illness
4 (14)
Close contact with any extended
family member ill with respiratory
illness 15 days prior to illness
5 (17)
Any household member affected
with similar illness
5 (17)
Any extended family member
affected with similar illness
4 (14)
Clinical presentation
History of fever 16 (55)
Cough 26 (90)
Fast breathing (tachypnea) 26 (90)
Nasal congestion/coryza 13 (45)
Runny nose/clear rhinorrhea 21 (72)
Shortness of breath (dyspnea) 25 (86)
Feeding difﬁculty 17 (59)
Chest wall retraction (intercostals
and/or subcostal recession)
11 (38)
Cyanosis 2 (7)
Loose motion 5 (17)
Clinical management
Oxygen therapy 23 (100)
Bronchodilators 23 (100)
Antibiotics 26 (90)
Nasal decongestants 23 (100)
Corticosteroids 5 (22)
Antiviral 0 (0)
Clinical outcomes or complications
Sepsis 0 (0)
Death 0 (0)
Recovery within 5 days 10 (36)
Still sick after 5 days of illness 11 (39)
a Categories are not mutually exclusive.
Table 2
Summary of respiratory viruses detected in nasal and throat swabs collected from
acute bronchiolitis cases admitted in the Meherpur General Hospital, July 2010
Virus types Total number of samples
with detectable RNA for
respiratory viruses (% of
total samples) (N = 23)
RSV 21 (91)
RSV alone 12 (52)
RSV and inﬂuenza A (H1N1)pdm09 6 (26)
RSV and adenovirus 2 (9)
RSV and inﬂuenza B 1 (4)
Inﬂuenza A (H1N1)pdm09 only 1 (4)
Inﬂuenza B only 1 (4)
Human parainﬂuenza virus 0
Human metapneumovirus 0
RSV, respiratory syncytial virus.
F. Haque et al. / International Journal of Infectious Diseases 16 (2012) e866–e871e870Acute bronchiolitis, most likely caused by RSV, was responsible
for more than a third of ARI admissions to Meherpur General
Hospital during July 2010. This ﬁnding is comparable to previous
studies conducted in low-income countries that have identiﬁed
RSV in 15–40% of hospital admissions for pneumonia or
bronchiolitis.25,26 We found no deaths among the cases that we
investigated. A previous study on children hospitalized with a
diagnosis of bronchiolitis in Bangladesh found a mortality rate of
2%.27 As we could not follow up all 101 cases in this investigation,
we may have underestimated the mortality among hospitalized
cases. It is also possible that the case deﬁnition we used did not
identify those infants aged <2 months who were at higher risk of
mortality from RSV bronchiolitis,12 as irritability, feeding difﬁculty,and breathing difﬁculty are often the only symptoms in this age
group.28 Indeed, since in approximately a third of these
investigated outbreak case patients other siblings or older family
members also developed similar symptoms within 1 week, this
suggests that the total community burden of RSV was greater than
only those children hospitalized. Since we surveyed only 29 out of
101 cases over a few days and because various respiratory
pathogens other than RSV could lead to similar symptoms, it is
possible that the ﬁndings of the survey cases may be different from
all outbreak-associated cases. However, the epidemiological and
the laboratory ﬁndings of the nine cases surveyed in the cluster
investigation to trace back discharged cases were comparable to
the ﬁndings of the 20 cases surveyed in the hospital, suggesting
that the 29 surveyed patients were representative of the larger
affected population.
Despite evidence from developed nations suggesting a very low
risk of secondary bacterial infection following RSV bronchiolitis29
and Bangladesh’s national bronchiolitis guidelines restricting
antibiotic use only to severe cases with laboratory and/or
radiological evidence of bacterial pneumonia,30 antibiotics were
administered to 90% of the case patients. Undue use of antibiotics,
variation in clinical care, and poor adherence to national guidelines
in the management of acute bronchiolitis have been reported
previously.12,31 Evidence from controlled trials, including one
multicenter randomized controlled trial that was conducted in ﬁve
tertiary care hospitals of Bangladesh, showed that antibiotics were
not effective in the management of bronchiolitis in low-income
countries with a high ARI burden.32,33 Further research within
Bangladesh could determine if this non-compliance to clinical
guidelines with regard to avoiding antibiotics in acute bronchioli-
tis results from structural issues, including a lack of diagnostic
facilities, or from attitudinal factors that consider antibiotics an
essential therapy for infectious disease management.
In a country where approximately 70% of the health care
expenditure is out-of-pocket for patients, the economic burden
associated with the hospital-based management of RSV bronchi-
olitis, particularly the cost associated with injectable antibiotic
therapy, can be catastrophic to the affected household.34 Speciﬁc
diagnostic tests, such as PCR for the detection of RSV in the
hospital, have led to the reduced prescription of antibiotics in the
management of bronchiolitis in the USA.31 The introduction of
affordable rapid diagnostic tests in the hospital setting for the
service users, including antigen detection tests with an overall
sensitivity of 80–90%,7 could decrease the indiscriminate use of
antibiotics and also reduce ﬁnancial loss. However, the practical
applicability and cost-effectiveness of introducing advanced
diagnostic techniques should be evaluated in the Bangladeshi
context.
F. Haque et al. / International Journal of Infectious Diseases 16 (2012) e866–e871 e871We identiﬁed this outbreak of RSV from newspaper reports.
Even though what we identiﬁed was not a novel respiratory
pathogen, following up on mass media reports of outbreaks might
be a valuable strategy to identify events of public health concern.
RSV, the leading cause of potentially life-threatening viral
respiratory tract infection in infants,4,5,35,36 likely contributes
signiﬁcantly to childhood morbidity and mortality in low-income
settings.37 Given the paucity of public health interventions to
prevent respiratory infections including RSV in low-income
settings, further research for identifying preventive strategies
including improvement of hand hygiene practices and cough
etiquette employed in developed nations38,39 should be priori-
tized.
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